Logo
x

Search

Subscribe Now

Cartesian Therapeutics

Cartesian Therapeutics’ Descartes-08 Gains the US FDA’s Rare Pediatric Disease Designation to Treat Juvenile Dermatomyositis

Cartesian Therapeutics’ Descartes-08 Gains the US FDA’s Rare Pediatric Disease Designation to Treat Juvenile Dermatomyositis

  • September 10, 2024
Cartesian Therapeutics’ Descartes-08 Gains the US FDA’s RMAT Designation to Treat Myasthenia Gravis

Cartesian Therapeutics’ Descartes-08 Gains the US FDA’s RMAT Designation to Treat Myasthenia Gravis

  • May 23, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.